Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Cardiology

Understanding Congenital Long QT Syndrome

At a Glance

Congenital Long QT Syndrome (LQTS) is a highly treatable genetic condition affecting the heart's electrical recharging system, not its physical structure. With proper management, including beta-blocker medications and avoiding trigger drugs, most people with LQTS live full, normal lives.

Receiving a diagnosis of Congenital Long QT Syndrome (LQTS) often brings a wave of fear, but it is important to start with a stabilizing fact: with proper diagnosis and management, the vast majority of people with LQTS live full, normal, and long lives [1][2]. While the name sounds complex, it describes a specific electrical timing issue in a heart that is otherwise structurally healthy and strong [3].

Understanding the “Electrical Reset”

To understand LQTS, it helps to distinguish between the “plumbing” and the “electricity” of the heart. Most heart conditions people worry about involve the plumbing (clogged arteries) or the structure (weak muscles). In LQTS, the heart’s structure is usually perfect [3].

The issue lies entirely in the repolarization—the “recharging” phase of the heart’s electrical cycle [4]. Think of your heart cells like a camera flash: after it fires (a heartbeat), it needs a few moments to recharge before it can fire again. In LQTS, the “recharging” takes slightly longer than it should [5].

This delay is caused by tiny “gates” on the surface of your heart cells called ion channels [4].

  • The “Jammed Door” (LQT1 and LQT2): In these types, the doors that let potassium out of the cell don’t open as quickly as they should, dragging out the recharge time [3][6].
  • The “Leaky Faucet” (LQT3): In this type, the doors that let sodium into the cell don’t close tightly enough, allowing a “trickle” that prevents the cell from resetting promptly [7][3].

Stabilizing Facts for the Newly Diagnosed

  1. You are not alone. LQTS is more common than many realize, affecting approximately 1 in 2,000 people [4][8].
  2. It is highly treatable. Most patients are successfully managed with daily medications called beta-blockers (like nadolol), which act as a “shield” for the heart [2][9].
  3. Knowledge is protection. Once you know the diagnosis, you can avoid specific triggers and medications that increase risk, significantly lowering the chance of a serious event [1][2].

What is “Concealed” LQTS?

You may hear the term concealed LQTS. This occurs when a person carries a genetic mutation for the condition but has a normal QTc interval (the measurement of the recharge time) on a standard ECG (electrocardiogram) [10][11]. Even though the “electricity” looks normal on a resting test, the underlying genetic “blueprint” still carries the trait [10]. These individuals still need to follow safety guidelines, such as avoiding certain medications, because the “concealed” trait can be “unmasked” by stress or specific drugs [10][12].

Navigating the Risks Honestly

While the risks of LQTS are serious, they are manageable. The primary concern is a specific type of rapid heart rhythm called Torsades de Pointes (TdP) [13].

  • Torsades de Pointes: This rhythm can cause brief fainting spells (syncope) or seizures as the brain momentarily gets less oxygen [13][14].
  • Ventricular Fibrillation (VF): In some cases, TdP can turn into VF, where the heart “quivers” instead of pumping. This is the cause of Sudden Cardiac Death (SCD) [13][15].

The goal of treatment is to prevent these rhythms from ever starting. For those at higher risk, doctors may recommend an ICD (Implantable Cardioverter-Defibrillator), a small device that can automatically correct a dangerous rhythm if it occurs [16][17]. By combining medication, trigger avoidance, and—if necessary—technology, the risk of a life-threatening event can be kept very low [1][2].

Common questions in this guide

What is concealed Long QT Syndrome (LQTS)?
Concealed LQTS means you have the genetic mutation for the condition, but your resting ECG shows a normal electrical recharge time. Even with a normal ECG, you are still at risk and need to follow safety guidelines and avoid certain medications.
How is Congenital Long QT Syndrome treated?
Most people with LQTS are successfully treated with daily beta-blocker medications like nadolol, which help shield the heart from dangerous rhythms. For those at higher risk, doctors may recommend an Implantable Cardioverter-Defibrillator (ICD) to automatically correct severe arrhythmias.
What causes the electrical delay in Long QT Syndrome?
The delay is caused by malfunctions in tiny gates on your heart cells called ion channels. Depending on your specific type of LQTS, these channels either do not let potassium out fast enough or let too much sodium leak in, slowing down the heart's electrical reset.
Can you live a normal life with Long QT Syndrome?
Yes, with a proper diagnosis and management plan, the vast majority of people with LQTS live full, normal, and long lives. Understanding your specific triggers and sticking to your treatment plan keeps the risk of serious events very low.
What are the risks of having Long QT Syndrome?
The primary concern is a rapid heart rhythm called Torsades de Pointes. This rhythm can cause temporary fainting spells or seizures because the brain briefly receives less oxygen, and in severe cases, it can lead to ventricular fibrillation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which genotype do I (or my child) have, and how does that influence our daily activity and triggers?
  2. 2.Is my (or my child's) case considered 'concealed' LQTS, and how does that change our risk level?
  3. 3.What is our specific QTc measurement, and what is our target range while on medication?
  4. 4.Based on my risk profile, is a beta-blocker like nadolol the best first step, or do we need to discuss an ICD?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Molecular Pathophysiology of Congenital Long QT Syndrome.

    Bohnen MS, Peng G, Robey SH, et al.

    Physiological reviews 2017; (97(1)):89-134 doi:10.1152/physrev.00008.2016.

    PMID: 27807201
  2. 2

    Clinical and genetic profile of congenital long QT syndrome in Hong Kong: a 20-year experience in paediatrics.

    Kwok SY, Liu AP, Chan CY, et al.

    Hong Kong medical journal = Xianggang yi xue za zhi 2018; (24(6)):561-570 doi:10.12809/hkmj187487.

    PMID: 30530868
  3. 3

    Compound and heterozygous mutations of KCNQ1 in long QT syndrome with familial history of unexplained sudden death: Identified by analysis of whole exome sequencing and predisposing genes.

    Lin Y, Zhao T, He S, et al.

    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2020; (25(1)):e12694 doi:10.1111/anec.12694.

    PMID: 31565860
  4. 4

    CONGENITAL LONG QT SYNDROME: A SYSTEMATIC REVIEW.

    Galić E, Bešlić P, Kilić P, et al.

    Acta clinica Croatica 2021; (60(4)):739-748 doi:10.20471/acc.2021.60.04.22.

    PMID: 35734489
  5. 5

    Precision medicine for long QT syndrome: patient-specific iPSCs take the lead.

    Yu Y, Deschenes I, Zhao MT

    Expert reviews in molecular medicine 2023; (25()):e5 doi:10.1017/erm.2022.43.

    PMID: 36597672
  6. 6

    Long QT Syndrome KCNH2 Variant Induces hERG1a/1b Subunit Imbalance in Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

    Feng L, Zhang J, Lee C, et al.

    Circulation. Arrhythmia and electrophysiology 2021; (14(4)):e009343 doi:10.1161/CIRCEP.120.009343.

    PMID: 33729832
  7. 7

    Long QT syndrome - Bench to bedside.

    Ponce-Balbuena D, Deschênes I

    Heart rhythm O2 2021; (2(1)):89-106 doi:10.1016/j.hroo.2021.01.006.

    PMID: 34113909
  8. 8

    Congenital Long QT Syndrome: A Focus on Risk Stratification and Management.

    Ranganathan D, Grondin S, Hadjeres R, Joza J

    Reviews in cardiovascular medicine 2025; (26(6)):36779 doi:10.31083/RCM36779.

    PMID: 40630465
  9. 9

    Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome.

    Mazzanti A, Maragna R, Vacanti G, et al.

    Journal of the American College of Cardiology 2018; (71(15)):1663-1671 doi:10.1016/j.jacc.2018.01.078.

    PMID: 29650123
  10. 10

    A case of congenital long QT syndrome, type 8, undergoing laparoscopic hysterectomy with general anesthesia.

    Chang SL, Chang CT, Hung WT, Chen LK

    Taiwanese journal of obstetrics & gynecology 2019; (58(4)):552-556 doi:10.1016/j.tjog.2019.05.031.

    PMID: 31307750
  11. 11

    Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram.

    Bos JM, Attia ZI, Albert DE, et al.

    JAMA cardiology 2021; (6(5)):532-538 doi:10.1001/jamacardio.2020.7422.

    PMID: 33566059
  12. 12

    Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.

    Koponen M, Marjamaa A, Hiippala A, et al.

    Circulation. Arrhythmia and electrophysiology 2015; (8(4)):815-23 doi:10.1161/CIRCEP.114.002654.

    PMID: 26063740
  13. 13

    A new paradigm for predicting risk of Torsades de Pointes during drug development: Commentary on: "Improved prediction of drug-induced Torsades de Pointes through simulations of dynamics and machine learning algorithms".

    McCauley MD, Darbar D

    Clinical pharmacology and therapeutics 2016; (100(4)):324-6 doi:10.1002/cpt.408.

    PMID: 27301674
  14. 14

    Arrhythmias due to Inherited and Acquired Abnormalities of Ventricular Repolarization.

    Locati ET, Bagliani G, Cecchi F, et al.

    Cardiac electrophysiology clinics 2019; (11(2)):345-362 doi:10.1016/j.ccep.2019.02.009.

    PMID: 31084855
  15. 15

    Torsade de pointes arrhythmias arise at the site of maximal heterogeneity of repolarization in the chronic complete atrioventricular block dog.

    Dunnink A, Stams TRG, Bossu A, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2017; (19(5)):858-865 doi:10.1093/europace/euw087.

    PMID: 28525920
  16. 16

    Identifying genomic variant associated with long QT syndrome type 2 in an ecuadorian mestizo individual: a case report.

    Tamayo-Trujillo R, Ibarra-Castillo R, Laso-Bayas JL, et al.

    Frontiers in genetics 2024; (15()):1395012 doi:10.3389/fgene.2024.1395012.

    PMID: 38957812
  17. 17

    Implantable cardioverter-defibrillator explantation for overdiagnosed or overtreated congenital long QT syndrome.

    Gaba P, Bos JM, Cannon BC, et al.

    Heart rhythm 2016; (13(4)):879-85.

    PMID: 26681611

This page provides educational information about Congenital Long QT Syndrome. It does not replace professional medical advice, and you should always consult your cardiologist or electrophysiologist about your specific risks and treatment plan.

Get notified when new evidence is published on Congenital long QT syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.